(NYSE: DHR) Danaher's forecast annual revenue growth rate of 7.4% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 7.01%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.76%.
Danaher's revenue in 2024 is $22,519,000,000.On average, 8 Wall Street analysts forecast DHR's revenue for 2024 to be $17,700,711,417,035, with the lowest DHR revenue forecast at $17,605,156,187,067, and the highest DHR revenue forecast at $17,763,144,626,262. On average, 8 Wall Street analysts forecast DHR's revenue for 2025 to be $19,173,212,555,646, with the lowest DHR revenue forecast at $19,017,349,146,137, and the highest DHR revenue forecast at $19,276,130,209,832.
In 2026, DHR is forecast to generate $20,668,461,659,306 in revenue, with the lowest revenue forecast at $20,477,197,877,256 and the highest revenue forecast at $20,831,068,279,084.